{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:04:37Z","timestamp":1779710677245,"version":"3.53.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004006","name":"Istanbul University Scientific Research Projects Unit","doi-asserted-by":"publisher","award":["38721"],"award-info":[{"award-number":["38721"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejps.2026.107495","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:35:32Z","timestamp":1772483732000},"page":"107495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and characterization of a carrier-free dry powder inhaler formulation of clarithromycin"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9474-3611","authenticated-orcid":false,"given":"Cemre Irem","family":"Ayguler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Fael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayram","family":"Hacioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Yildiz-Pekoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107495_bib0001","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/pharmaceutics17060729","article-title":"Clarithromycin-loaded albumin-based nanoparticles for improved antibacterial and anticancer performance","volume":"17","author":"Alshaer","year":"2025","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2026.107495_bib0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2011.09.021","article-title":"Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation","volume":"421","author":"Amaro","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2018.07.030","article-title":"Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties","volume":"123","author":"Ambrus","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107495_bib0004","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.addr.2013.07.020","article-title":"Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases","volume":"65","author":"Andrade","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107495_bib0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/med.20140","article-title":"Nanoparticle formulations in pulmonary drug delivery","volume":"29","author":"Bailey","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejps.2026.107495_bib0006","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2147\/COPD.S297980","article-title":"Lung deposition and inspiratory flow rate in patients with chronic obstructive pulmonary disease using different inhalation devices: a systematic literature review and expert ppinion","volume":"16","author":"Baloira","year":"2021","journal-title":"Int. J. Chron. Obs. Pulmon. Dis."},{"key":"10.1016\/j.ejps.2026.107495_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40199-019-00317-9","article-title":"The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin","volume":"28","author":"Barazesh","year":"2020","journal-title":"DARU J Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107495_bib0008","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/03639045.2019.1620268","article-title":"Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and in vitro\u2013in silico lung deposition results","volume":"45","author":"Benke","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential \u2013What they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2026.107495_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/jamp.2015.1220","article-title":"Effect of flow rate on in vitro aerodynamic performance of NEXThaler in comparison with Diskus and Turbohaler dry powder inhalers","volume":"29","author":"Buttini","year":"2015","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107495_bib0011","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpb.2016.09.020","article-title":"Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying","volume":"109","author":"Ceschan","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0012","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1208\/s12249-014-0092-0","article-title":"Mechanisms of pharmaceutical aerosol deposition in the respiratory tract","volume":"15","author":"Cheng","year":"2014","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2026.107495_bib0013","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1472-9792(08)70005-2","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejps.2026.107495_bib0014","series-title":"CLSI Supplement M100","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2021"},{"key":"10.1016\/j.ejps.2026.107495_bib0015","series-title":"Modern Farmas\u00f6tik Teknoloji","first-page":"263","article-title":"Kolloidler","author":"\u00c7elebi","year":"2009"},{"key":"10.1016\/j.ejps.2026.107495_bib0017","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1007\/s11095-015-1745-8","article-title":"Inhalable clarithromycin microparticles for treatment of respiratory infections","volume":"32","author":"Dimer","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107495_bib0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jddst.2017.07.016","article-title":"Formulation of clarithromycin floating microspheres for eradication of Helicobacter pylori","volume":"41","author":"El Nashar","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2026.107495_bib0019","series-title":"Guideline On the Pharmaceutical Quality of Inhalation and Nasal Products","year":"2012"},{"key":"10.1016\/j.ejps.2026.107495_bib0020","first-page":"809","article-title":"Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique","volume":"13","author":"Esfandi","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107495_bib0021","first-page":"1535","article-title":"Development of carrier free montelukast dry powder inhalation formulation","volume":"77","author":"Faramarzi","year":"2015","journal-title":"Pharm. Ind"},{"key":"10.1016\/j.ejps.2026.107495_bib0022","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.2042-7158.2012.01465.x","article-title":"Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state","volume":"64","author":"Gad","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107495_bib0023","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/pharmaceutics15051488","article-title":"Dry powder inhalation for lung delivery in cystic fibrosis","volume":"15","author":"Han","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2026.107495_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.addr.2014.04.005","article-title":"Dry powders for oral inhalation free of lactose carrier particles","volume":"75","author":"Healy","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107495_bib0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ejpb.2008.04.020","article-title":"Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide","volume":"69","author":"Healy","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0026","series-title":"Q2(R2) Validation of Analytical Procedures","year":"2023"},{"key":"10.1016\/j.ejps.2026.107495_bib0027","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1208\/s12249-021-02115-6","article-title":"Preparation and characterization of pH-independent sustained-release tablets containing hot melt extruded solid dispersions of clarithromycin","volume":"22","author":"Ijaz","year":"2021","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2026.107495_bib0028","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/pharmaceutics12010014","article-title":"Spray dried formulations for inhalation\u2014Meaningful characterisation of powder properties","volume":"12","author":"J\u00fcptner","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107495_bib0029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4155\/ppa-2017-0019","article-title":"Pulmonary drug delivery system: newer patents","volume":"6","author":"Kaur","year":"2017","journal-title":"Pharm. Pat. Anal"},{"key":"10.1016\/j.ejps.2026.107495_bib0030","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/microorganisms10061171","article-title":"Assessing the synergistic activity of clarithromycin and therapeutic oils encapsulated in sodium alginate based floating microbeads","volume":"10","author":"Khan","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejps.2026.107495_bib0031","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107495_bib0032","first-page":"209","article-title":"Suspension stability; why particle size, zeta potential and rheology are important","volume":"20","author":"Larsson","year":"2012","journal-title":"Annu. Trans. Nord. Rheol. Soc."},{"key":"10.1016\/j.ejps.2026.107495_bib0033","first-page":"481","article-title":"Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges","volume":"10","author":"Lee","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107495_bib0034","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/antibiotics12030484","article-title":"Current and emerging inhaled antibiotics for chronic pulmonary Pseudomonas aeruginosa and Staphylococcus aureus infections in cystic fibrosis","volume":"12","author":"Li","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejps.2026.107495_bib0035","first-page":"63","article-title":"Formulation and characterization of pulmonary drug delivery systems","volume":"89","author":"Magramane","year":"2019","journal-title":"Acta Pharm. Hung."},{"key":"10.1016\/j.ejps.2026.107495_bib0036","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/ph16121658","article-title":"Inhalation dosage forms: a focus on dry powder inhalers and their advancements","volume":"16","author":"Magramane","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2026.107495_bib0037","doi-asserted-by":"crossref","first-page":"172","DOI":"10.14356\/kona.2023013","article-title":"Performance testing for dry powder inhaler products: towards clinical relevance","volume":"40","author":"Maloney","year":"2023","journal-title":"KONA Powder J."},{"key":"10.1016\/j.ejps.2026.107495_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2016.04.009","article-title":"Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: clarithromycin versus its hydrochloride salt","volume":"104","author":"Manniello","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0039","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/ijms18051062","article-title":"Inhaled antibiotic therapy in chronic respiratory diseases","volume":"18","author":"Maselli","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107495_bib0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/pharmaceutics17060770","article-title":"Lung delivery of lactose-free microparticles loaded with azithromycin for the treatment of bacterial infections","volume":"17","author":"Molina","year":"2025","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2026.107495_bib0041","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2013.09.022","article-title":"Precipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: influencing factors on physicochemical properties and stability","volume":"457","author":"Morakul","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0042","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/17425247.2015.977783","article-title":"Dry powder inhalers in COPD, lung inflammation and pulmonary infections","volume":"12","author":"Muralidharan","year":"2015","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107495_bib0043","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1021\/acs.molpharmaceut.3c00395","article-title":"Inhalable excipient-free dry powder of tigecycline for the treatment of pulmonary infections","volume":"20","author":"Nair","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0044","series-title":"Methods For Determining Bactericidal Activity of Antimicrobial agents. Approved guideline M26-A","year":"2002"},{"key":"10.1016\/j.ejps.2026.107495_bib0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00044011-200525020-00006","article-title":"A survey of the quality of generic clarithromycin products from 18 countries","volume":"25","author":"Nightingale","year":"2005","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejps.2026.107495_bib0046","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejps.2009.05.007","article-title":"Excipient-free nanoporous microparticles of budesonide for pulmonary delivery","volume":"37","author":"Nolan","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107495_bib0047","first-page":"801","article-title":"Empirical modeling of the fine particle fraction for carrier-based pulmonary delivery formulations","volume":"10","author":"Pac\u0142awski","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2026.107495_bib0048","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/pharmaceutics17040486","article-title":"Nanoparticle-based dry powder inhaler containing ciprofloxacin for enhanced targeted antibacterial therapy","volume":"17","author":"Party","year":"2025","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2026.107495_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124248","article-title":"A review on micro and nanoengineering in powder-based pulmonary drug delivery","volume":"659","author":"Pasero","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0050","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.drudis.2013.11.013","article-title":"Alternative carriers in dry powder inhaler formulations","volume":"19","author":"Rahimpour","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2026.107495_bib0051","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4187\/respcare.05500367","article-title":"The inhalation of drugs: advantages and problems","volume":"50","author":"Rau","year":"2005","journal-title":"Respir. Care"},{"key":"10.1016\/j.ejps.2026.107495_bib0052","article-title":"A comprehensive overview of dry powder inhalers for pulmonary drug delivery: challenges, advances, optimization techniques, and applications","volume":"84","author":"Shahin","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2026.107495_bib0053","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1208\/s12249-014-0210-z","article-title":"Factors influencing aerodynamic particle size distribution of suspension pressurized metered dose inhalers","volume":"16","author":"Sheth","year":"2015","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.ejps.2026.107495_bib0054","doi-asserted-by":"crossref","first-page":"8","DOI":"10.22159\/ajpcr.2017.v10i2.14282","article-title":"Advancements in dry powder inhaler","volume":"10","author":"Shetty","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.ejps.2026.107495_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/17425247.2020.1702643","article-title":"Physical stability of dry powder inhaler formulations","volume":"17","author":"Shetty","year":"2020","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107495_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126454","article-title":"Electrosprayed co-crystals of levofloxacin for inhalation: a strategy for excipient-free dry powder antibiotics","volume":"688","author":"Sun","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0057","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejpb.2013.03.020","article-title":"Steroid\/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery","volume":"85","author":"Tewes","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0058","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1208\/s12249-025-03140-5","article-title":"Preparation and study of erythromycin dry powder inhaler based on ternary complex structure","volume":"26","author":"Yang","year":"2025","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2026.107495_bib0059","series-title":"Emerging Nanotechnologies in immunology: the design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines","first-page":"165","article-title":"Nanopharmaceuticals","author":"Yurdasiper","year":"2018"},{"key":"10.1016\/j.ejps.2026.107495_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125601","article-title":"Particulate platform for pulmonary drug delivery: recent advances of formulation and fabricating strategies","volume":"676","author":"Zhang","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107495_bib0061","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2014.10.022","article-title":"Inhaled formulations and pulmonary drug delivery systems for respiratory infections","volume":"85","author":"Zhou","year":"2015","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:51:23Z","timestamp":1779709883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"alternative-id":["S0928098726000692"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107495","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a carrier-free dry powder inhaler formulation of clarithromycin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107495"}}